Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Epigenetic Mechanisms That Drive Genetic Risk for Juvenile Arthritis. James Jarvis (Principal Investigator). NIH/NIAMS. $3,047,449. 10/1/2022-9/1/2027.
  • Training the Next Generation of Physician Scientists. Oscar Gómez (Co-Investigator). NIAID/NIH. 9/1/2022-8/1/2027.
  • Adaptation of an evidence-based family program for obesity Prevention in health care contexts: Testing outcomes and mechanisms with first-time military parents and their infants. Stephanie Anzman-Frasca (Co-Investigator). NIH. 7/1/2022-6/1/2027.
  • Effects of pulse consumption on maternal and child health. Xiaozhong Wen (Principal Investigator). United States Department of Agriculture. $500,260. 8/1/2021-7/1/2026.
  • Optimizing Chest Compressions for Bradycardia during Neonatal Resuscitation. Praveen Chandrasekharan (Principal Investigator). R01 - Eunice Kennedy Shriver National Institute of Child Health & Human Development. $1,500,000. 5/1/2021-4/1/2026.
  • A 5-Year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions. Heather Lehman (Principal Investigator). TARGET PharmaSolutions, Inc. 1/1/2020-12/1/2025.
  • Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial. Kara Kelly (Contributor). National Cancer Institute. 8/1/2020-7/1/2025.
  • Using B cell responses to discover the etiology of Kawasaki disease. Mark Hicar (Principal Investigator). American Heart Association. $300,000. 8/1/2022-7/1/2025.
  • Effects of maternal egg consumption during pregnancy and postpartum on maternal and child health. Xiaozhong Wen (Principal Investigator). Egg Nutrition Center/American Egg Board. $203,322. 5/1/2023-6/1/2025.
  • Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial. Kara Kelly (Contributor). CIHR. 4/1/2020-3/1/2025.
  • Therapeutic synergy between polarized dendritic cells, irradiation and PD-1 blockade in pediatric patients and adolescents and young adults with solid tumors. Ajay Gupta (Principal Investigator). Wildermuth Foundation. $30,000. 7/1/2023-7/1/2024.
  • Therapeutic synergy between polarized dendritic cells, irradiation and PD-1 blockade in pediatric patients and adolescents and young adults with solid tumors. Ajay Gupta (Principal Investigator). CTSI K Scholar Program. 7/1/2022-6/1/2024.
  • Optimizing the duration of delayed umbilical cord clamping during preterm resuscitation using an asphyxiated model. Praveen Chandrasekharan (Co-Principal Investigator). ZOLL Foundation. $80,000. 9/1/2022-6/1/2024.
  • Deuterium Magnetic Resonance Imaging of graft-versus-host disease. Nataliya Buxbaum (Principal Investigator). Clinical Research Investigator-Initiated Studies Program (CRI-ISP) Award. $75,000. 4/1/2023-3/1/2024.
  • Children‘s Oncology Group Scientific Leadership Grant. Kara Kelly (Co-Investigator). National Cancer Institute/Children‘s Hospital of Philadelphia. 3/1/2012-2/1/2024.
  • Improving Kangaroo Care Rates in Level 4 NICU. Munmun Rawat (Principal Investigator). Prolacta Biosciences. 1/1/2023-1/1/2024.
  • Epinephrine via Laryngeal Mask versus Endotracheal tube. Munmun Rawat (Principal Investigator). Wildermuth Foundation. 1/1/2022-12/1/2023.
  • Exploiting Replication Stress in Ewing Sarcoma. Ajay Gupta (Principal Investigator). Hyundai Hope on Wheels. 1/1/2022-12/1/2023.
  • Hyundai Hope on Wheels Impact Award. Nataliya Buxbaum (Principal Investigator). Hyundai. $100,000. 1/1/2023-12/1/2023.
  • Development of Pediatric Patient Derived Tumor Models. Matthew Barth (Principal Investigator). Roswell Park Alliance Foundation. 12/1/2020-11/1/2023.